4,411
Participants
Start Date
September 30, 2008
Primary Completion Date
November 30, 2008
Study Completion Date
December 31, 2008
Choice of TIV or FluMist with baseline advertisement
An intervention arm offering choice of TIV or FluMist with baseline advertisement, including advertisement to highlight the availability of FluMist
Choice of TIV or FluMist with enhanced advertisement and incentives
An intervention arm offering choice of TIV or FluMist with enhanced advertisement and additional incentives for receiving an influenza vaccination
Control - Usual care offering TIV only with baseline advertisement
A control arm of usual care offering TIV with baseline advertisement
Larwenceville
Rochester
Rochester
Rochester
Washington D.C.
Calverton
Laurel
Cockeysville
Hunt Valley
Columbia
Columbia
Hanover
Crofton
Sparks
Baltimore
Baltimore
Baltimore
Baltimore
Baltimore
Baltimore
Annapolis
Fredericksburg
High Point
Tampa
La Grange
Louisville
Louisville
Lawrenceburg
Hebron
Hamilton
Lebanon
West Chester
Cincinnati
Denver
Boulder
Albuquerque
Santa Monica
Chatsworth
Thousand Oaks
Sunnyvale
San Francisco
Novato
Sacramento
Sacramento
Santa Clara
Basking Ridge
Morristown
Lead Sponsor
Collaborators (1)
Passport Health
INDUSTRY
University of Pittsburgh
OTHER
MedImmune LLC
INDUSTRY